Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
Amgen(AMGN) stock is priced at $366.21, giving the company a market capitalization of 197.44B. It carries a P/E multiple of 25.74 and pays a dividend yield of 2.6%.
As of 2026-03-15, Amgen(AMGN) stock has fluctuated between $365.93 and $372.98. The current price stands at $366.21, placing the stock +0.1% above today's low and -1.8% off the high.
Amgen(AMGN) shares are trading with a volume of 1.4M, against a daily average of 2.37M.
During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.
During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.
AMGN News
In early March 2026, Amgen announced a US$2.52 per-share second-quarter dividend payable on June 5, 2026, and presented its growth and pipeline outlook at the L...
Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run direct-to-consumer platform for pharmaceutical...
Amgen (NasdaqGS:AMGN) has completed a Phase 3 trial for ABP 206, a potential biosimilar to Opdivo (nivolumab). The study supports planned regulatory filings an...
Analyst ratings
53%
of 38 ratingsMore AMGN News
Image source: The Motley Fool. Thursday, March 12, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Robert Spignesi Chief Financi...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained Quick Read Jefferies initiated on Gilead (GILD) w...
Jefferies initiated coverage of Amgen (AMGN) with a Hold rating and $350 price target With the stock having run up about 35% over the past six months, driven by...
Key Points Novo Nordisk is a top player in the weight loss market and has several more products on the way. Amgen's most advanced candidate in this space coul...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.